Cancer drug discovery technologies get a £4.5m boost

Imperial academics will lead a project to improve imaging technologies for cancer drug discovery, funded by CRUK and European partners. The funding is part of the Cancer Research UK Accelerator Awards programme, which provides five years of funding for international projects. The £4.5m project will be led by Professor Paul French from the Department of Physics at Imperial, with collaborators across the Faculties of Natural Sciences and Medicine, and partners in the Francis Crick Institute, the University of Edinburgh, the Institute of Cancer Research and the Instituto de Recerca Biomedica in Barcelona. More realistic cancer models. The project aims to improve screening for new cancer drugs. Currently, drugs are typically tested using conventional microscopy to image thin layers of cancer cells. However, this approach does not reflect the true complexity of cancer inside people.